We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
232 hedge funds and large institutions have $1.89B invested in Corcept Therapeutics in 2023 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 87 increasing their positions, 77 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
15% more capital invested
Capital invested by funds: $1.65B → $1.89B (+$243M)
13% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 77
3.06% more ownership
Funds ownership: 77.43% → 80.49% (+3.1%)
5% less funds holding
Funds holding: 243 → 232 (-11)
17% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 42
37% less call options, than puts
Call options by funds: $22.5M | Put options by funds: $36M
Holders
232
Holders Change
-11
Holders Change %
-4.53%
% of All Funds
3.7%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
35
Increased
87
Reduced
77
Closed
42
Calls
$22.5M
Puts
$36M
Net Calls
-$13.5M
Net Calls Change
-$3.98M
Top Buyers
| 1 |
Millennium Management
New York
|
+$50M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
+$33.9M |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$17.4M |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$13.9M |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$11M |
Top Sellers
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$18.5M |
| 2 |
Man Group
London,
United Kingdom
|
-$15M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$11.2M |
| 4 |
Renaissance Technologies
New York
|
-$11M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.95M |
